SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-013065
Filing Date
2023-08-03
Accepted
2023-08-03 07:45:22
Documents
16
Period of Report
2023-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K elev-20230803x8k.htm   iXBRL 8-K 46646
2 EX-5.1 elev-20230803xex5d1.htm EX-5.1 39827
3 EX-99.1 elev-20230803xex99d1.htm EX-99.1 72519
4 GRAPHIC elev-20230803xex5d1001.jpg GRAPHIC 11716
  Complete submission text file 0001558370-23-013065.txt   327810

Data Files

Seq Description Document Type Size
5 EX-101.SCH elev-20230803.xsd EX-101.SCH 3818
6 EX-101.DEF elev-20230803_def.xml EX-101.DEF 2823
7 EX-101.LAB elev-20230803_lab.xml EX-101.LAB 17910
8 EX-101.PRE elev-20230803_pre.xml EX-101.PRE 11887
10 EXTRACTED XBRL INSTANCE DOCUMENT elev-20230803x8k_htm.xml XML 4990
Mailing Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110
Business Address 101 FEDERAL STREET SUITE 1900 BOSTON MA 02110 6463459464
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 231138113
SIC: 2836 Biological Products, (No Diagnostic Substances)